EDAP TMS S.A. (EDAP)'s Ablatherm-HIFU Receives Two Best Poster Awards at 2013 American Urological Association Annual Meeting
5/14/2013 9:21:16 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
LYON, France, May 14, 2013 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, highlighted its positive reception at the American Urological Association (AUA) 2013 Annual Meeting, held in San Diego on May 4-8, 2013. At the meeting, four scientific abstracts were presented regarding the outcomes for HIFU treatment of prostate cancer, and two regarding clinical use of the Sonolith lithotripter and its exclusive ultrasound Visio Track® localization system. Two of the HIFU posters, #1208 and #1496, entitled The importance of biopsies in ablation therapies for prostate cancer: Start of salvage treatment for persistent positive biopsies after HIFU and HIFU treatment outcomes for localized prostate cancer from the first European centers, respectively, received Best Poster awards from the AUA.
Help employers find you! Check out all the jobs and post your resume.